Oncosil Medical Ltd (OSL) — Cash Flow Reinvestment Rate
Latest as of June 2015:
0.07x
Oncosil Medical Ltd (OSL) has a Cash Flow Reinvestment Rate of 0.07x as of June 2015, reinvesting AU$43.85K (capex AU$43.85K ) from operating cash flow of AU$596.28K. See OSL free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.07x
(Capex + Investments) / Operating CF
Total Reinvested
AU$43.85K
Capex + Investments
Operating Cash Flow
AU$596.28K
AUD
Capital Expenditures
AU$43.85K
AUD
Oncosil Medical Ltd Cash Flow Reinvestment Rate (2006–2010)
Historical reinvestment intensity for Oncosil Medical Ltd across 2 annual periods. For the full cash flow conversion analysis, see OSL operating cash flow.
Annual Cash Flow Reinvestment Rate for Oncosil Medical Ltd (2006–2010)
Year-by-year capital reinvestment analysis for Oncosil Medical Ltd. See Oncosil Medical Ltd (OSL) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | AU$30.48K | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$271.11K | AU$195.51K | AU$271.11K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow